Oncopeptides AB listed on Nasdaq Stockholm main market
February 22, 2017
Oncopeptides AB (publ) hereby announces the outcome relating to the offering to acquire shares in the company and the listing on Nasdaq Stockholm. The offering attracted strong interest among Swedish and international investors and the offering was oversubscribed several times.
For further information, please visit the company website